Join Us | November 12-14th
Northern New England MedTech Conference
The most collaborative healthcare conference, where technology meets clinicians, payers, and patients to advance health and wellness – back for its 5th year.
WEDNESDAY
11.12.25 | 12PM – 6PM
Day 1
1:00 PM
Registration Opens
1:30 PM – 2:30 PM
Expert Office Hours
Snag a focused 10-minute 1:1 with top regulatory, legal, clinical, and go-to-market advisors ready to pressure-test your plan or answer your hardest questions.
2:30 PM–4:00 PM
Innovation Showcase
Earliest Ventures Take the Stage
The conference opens with a curated exhibition for undergraduate & graduate students, labs, and new founders with early-stage concepts (<$100K raised). Exhibits use the Business Model Canvas format and are presented to the conference audience of clinicians, founders, technologists, investors, and industry leaders.
Participants have the opportunity to earn four unique awards:
1. Most Ready for Funding
2. Highest Clinical Impact
3. Most Innovative Technology
4. Most Applicable to Rural Healthcare
4:30 PM–4:30 PM
Pitch Competition Introduction
Ibraheem Badejo, PhD, MLS, Senior Director of External Innovation at Johnson & Johnson, will open the 2025 Northern New England MedTech Conference with a timely address aligned with the Day 1 Innovation Showcase, Pitch Competition, and early-stage research poster sessions.
4:30 PM–6:00 PM
Pitch Competition
2025 MedTech Collaborative Cohort
The MedTech Collaborative Pitch Competition is your chance to showcase your health innovation in front of investors, partners, and press, and walk away with valuable feedback, visibility, and momentum. Finalists’ pitches will consist of a 5 minute presentation followed by 5 minutes of Q&A from judges.
2025 Pitch Judges:
Jeff Chu, MS brings decades of experience as a medical device developer and technologist to his role at Features Capital. His deep expertise in software, hardware, biomechanics, and IP strategy helps him identify and support high-impact innovations poised for market success.
Shannon Bean, MS, BS is Principal at Coastal Enterprises Ventures (CEI Ventures), where she leads investments across industries with a focus on socially responsible growth. She brings expertise in venture capital, business development, and strategic partnerships, having previously held roles at The Jackson Laboratory, Johnson & Johnson, and Quest Diagnostics.
Phane Mane, MBA is Global Lead of AI Product Strategy & Delivery at Boston Scientific. An IT strategist with more than 20 years of experience applying technology to solve complex business problems, he focuses on generative AI, digital commerce, and global go-to-market initiatives.
Amanda Black, MBA, is an Investment Director at Farallon Capital Management, where she focuses on healthcare investments across both public and private markets. She previously worked on Carlyle’s healthcare private equity team, and brings a distinctive perspective that spans public equities, private investments, and investment banking across the healthcare sector.
November 12, 4:30 PM–6:00 PM
Pitch Competition
2025 MedTech Collaborative Cohort
The MedTech Collaborative Pitch Competition is your chance to showcase your health innovation in front of investors, partners, and press, and walk away with valuable feedback, visibility, and momentum. Finalists’ pitches will consist of a 5 minute presentation followed by 5 minutes of Q&A from judges.
2025 Pitch Judges:
Jeff Chu, MS brings decades of experience as a medical device developer and technologist to his role at Features Capital. His deep expertise in software, hardware, biomechanics, and IP strategy helps him identify and support high-impact innovations poised for market success.
Shannon Bean, MS, BS is Principal at Coastal Enterprises Ventures (CEI Ventures), where she leads investments across industries with a focus on socially responsible growth. She brings expertise in venture capital, business development, and strategic partnerships, having previously held roles at The Jackson Laboratory, Johnson & Johnson, and Quest Diagnostics.
Phane Mane, MBA is Global Lead of AI Product Strategy & Delivery at Boston Scientific. An IT strategist with more than 20 years of experience applying technology to solve complex business problems, he focuses on generative AI, digital commerce, and global go-to-market initiatives.
Amanda Black, MBA, is an Investment Director at Farallon Capital Management, where she focuses on healthcare investments across both public and private markets. She previously worked on Carlyle’s healthcare private equity team, and brings a distinctive perspective that spans public equities, private investments, and investment banking across the healthcare sector.
6:00 PM–8:00 PM
Enercon Reception at Shipyard Brewing
Celebrate with an evening of conversation, connection, and refreshments. Special annoucement from Enercon. Open to all attendees.
THURSDAY
11.13.2025 | 8AM – 6PM
THURSDAY
11.13.2025 | 8AM – 6PM
Day 2
Day 2
Future of Care Conversations
Future of Care Conversations
8:00 AM
Opening Address and Introductions
8:15 AM–9:00 AM
Federal Flux: Navigating the Shifting Landscape of Medical Innovation Funding
The funding landscape for healthcare innovation is rapidly evolving. With shifting priorities at agencies like NIH and DoD, growing involvement from family foundations, tariff-related headwinds, and increased scrutiny from private funders. See Full Session Details ›
9:00 AM–9:45 AM
Place-Based Solutions: Healthcare Technology Addressing Rural Challenges
As rural communities grapple with diminishing access to acute care, a surprising coalition of tech and retail leaders is rising to meet the challenge. Large corporations like Best Buy Health, Amazon, CVS, and more are reshaping…› See Full Session Details ›
10:00 AM–10:45 AM
HealthTech Hustle: Revenue Models That Work
Innovative health solutions don’t sell themselves, especially in today’s evolving and complex reimbursement environment. Whether you’re approaching hospital systems, adapting to changes in Medicare Advantage…› See Full Session Details ›
10:45 AM–11:30 AM
Hospital at Home: Changes in Chronic & Long-Term Care
The next frontier of chronic care is happening at home. Advances in technology are enabling treatments once reserved for hospital settings to move into the living room. From mobile imaging units and home infusion therapies to remote patient monitoring, telehealth, and AI-enabled diagnostics…› See Full Session Details ›
11:30 AM–12:00 PM
State of the MedTech Industry: Bank of America Financing Update
Hear directly from Bruno Stembaum, Managing Director of Medical Technology Investment Banking at Bank of America, as he shares his perspective on the current and future state of medtech financing…› See Full Session Details ›
1:15 PM–1:45 PM
Lunch and Networking Breakouts
Over lunch, participants are invited to join facilitated discussions at themed networking tables. Each table will focus on a core aspect of the MedTech journey, offering a chance to share experiences, exchange insights, and connect with peers facing similar challenges. Attendees are welcome to rotate between tables to broaden their perspective.
1:15 PM–1:45 PM
KEYNOTE ADDRESS
Reha Jhunjhunwala, Senior Director, Digital Health Products
November 13, 2:00 PM–2:30 PM
The AI Diagnosis Dilemma: Innovation Meets Skepticism
From reading scans to analyzing skin lesions, AI is rapidly emerging as a diagnostic tool, but can it be trusted? This session features a structured point-counterpoint discussion…› See Full Session Details ›
3:15 PM–4:00 PM
Data-Driven Care: Playing to Win with Healthcare Analytics
Data is only powerful if it’s put to work, and across the country, healthcare innovators are proving what’s possible. This session explores real-world examples of how longitudinal patient data…›
4:00 PM–4:45 PM
Future-Proof: How Technology Will Enable Resilience in Healthcare
From pandemics to workforce strain, tomorrow’s challenges will test healthcare systems in ways we can’t fully predict. This forward-looking session explores what it takes to build true resilience….›
5:00 PM–6:00 PM
Roux Institute Venture Showcase
The Roux Institute’s Future of Healthcare Founder Residency will present its most promising portfolio companies whose groundbreaking innovations are transforming the way communities, clinicians, health executives, and patients interact with and within the healthcare system.
What you can expect:
- Proven Market TractionEach presenting company has demonstrated real-world impact, validated business models, and measurable outcomes that are already reshaping how patients, providers, and health systems operate.
- Game-Changing TechnologiesFrom AI-powered diagnostic platforms to revolutionary patient engagement solutions, these companies are solving healthcare’s most pressing challenges with unprecedented innovation.
- Strategic Investment OpportunitiesAccess exclusive deal flow from Northern New England’s most selective healthcare accelerators. These founders have been rigorously vetted, intensively mentored, and are primed for rapid scaling.
- Partnership PotentialConnect directly with visionary entrepreneurs who are actively seeking strategic partnerships with forward-thinking investors ready to capitalize on healthcare’s $4.5 trillion transformation.
Over the past three years, the Roux Institute’s Future of Healthcare Founder Residency, in partnership with Northern Light Health, MaineHealth and Maine Venture Fund, has attracted 200+ startups to apply to Maine’s ecosystem, served more than 150 Maine patients, accelerated 29 companies, which have raised $14MM+ in capital. Together, we have partnered across institutions to solve complex community health challenges, accelerate ventures that drive investment and job creation, and build a health tech ecosystem that positions Maine as an innovation hub.
FRIDAY
11.14.2025 | 8AM – 12PM
Day 3
8:00AM
Breakfast & IdeaJam Kickoff
8:30 AM–12:00 PM
IdeaJam
(Prompt Debuts at Conference)
The Idea Jam is an interactive, rapid-fire session where innovators, clinicians, and entrepreneurs pressure-test emerging challenges at the frontier of healthtech.
You’ll need to attend to know what we’re solving, but here is an idea to get you thinking:
From the FDA’s evolving stance on consumer wearables like Whoop, to the 2026 CMS fee schedule for remote monitoring, to interoperability, compliance, and nutrition, there is a shifting boundary between wellness and regulated medical devices. With everyone wearing a sensor in the near future, how do we unlock proactive healthcare while navigating regulatory, reimbursement, business, and technical hurdles?
Join the Leaders Shaping Tomorrow’s Healthcare
Thank you to our sponsors:
Impact Sponsors:
Supporting Sponsors:
MTC Annual Sponsors:
November 13, 8:15 AM–9:00 AM
Federal Flux: Navigating the Shifting Landscape of Medical Innovation Funding
The funding landscape for healthcare innovation is rapidly evolving. With shifting priorities at agencies like NIH and DoD, growing involvement from family foundations, tariff-related headwinds, and increased scrutiny from private funders, securing the right capital has never been more complex. This session explores how innovators are responding to these changes—adjusting strategies, reassessing risk, and identifying the best-fit funding partners. Whether you’re pursuing federal grants, non-dilutive funding, or private investment, you’ll gain timely insights for making smart financial decisions in today’s healthcare economy.
John Hession
Moderator
Hub Angels
John Hession is tentatively confirmed as moderator. He brings extensive experience in venture funding, innovation, and startup growth.
Melissa Merkel
Impact Investing Manager, Center for Rural Innovation
Melissa Merkel is confirmed as a speaker representing the Center for Rural Innovation, where she supports initiatives to strengthen innovation and entrepreneurship in rural communities.
Jim Strickland
Senior Director Research Partnerships and Translation, The Roux Institute
Jim Strickland, formerly with MDI, is now the Director of Commercialization at the Roux Institute. He brings expertise in advancing early-stage innovation toward market readiness.
Suzanne Hamlin
Maine Technology Institute TAP
Suzanne is a business strategy and customer development consultant with a special interest in business startup, transition, transformation, and scaling. She has been a member of MTI’s SBIR/STTR TAP team since 2004 and has served as an SBIR/STTR grant application reviewer for both NSF and USDA. She has extensive experience leading teams and companies through organizational change, planning for new product commercialization, and applying new and emerging technologies for revenue growth and streamlining of work processes.
November 13, 9:00 AM–9:45 AM
Place-Based Solutions: Healthcare Technology Addressing Rural Challenges
As rural communities grapple with diminishing access to acute care, a surprising coalition of tech and retail leaders is rising to meet the challenge. Large corporations like Best Buy Health, Amazon, CVS, and more are reshaping how care is delivered, national Urgent Care Centers are competing with local healthcare providers, and numerous innovators are tackling accessibility issues — bringing healthcare to the doorstep of those who need it most. In this session, we explore place-based solutions designed to meet acute care needs in underserved regions. Join us for a deep dive into what’s driving this shift, how major players are deploying technology and physical infrastructure, and what it means for the future of rural health.
Marie Vienneau
Sr. VP and Regional President, Northern Light Health
Marie is currently a Sr. Vice President and Regional President of Northern Light Health Mercy Hospital. A Registered Nurse by training, she has served in progressive administrative roles in rural hospitals for 34 years, 20 of them as a rural hospital and critical access hospital CEO & President. Throughout her career, Marie has worked with Boards and communities to retain and expand access to rural healthcare clinical services through recruitment and retention of high-quality providers, enhancing reimbursement, and ensuring efficient operations to sustain care. She has also led major organizational initiatives, including the planning and construction of a new hospital, facilitated the transition of services during a hospital closure, and the introduction of mobile mammography services to increase access to preventative care. Collaboration with other partners has been key to this work. Marie serves her profession and community in many capacities, including being the past American College of Healthcare Executives Regent for Maine, Past-Chair of the Maine Hospital Association, Maine Hospital Solutions Board of Directors, Past-President of the Northern New England Association of Healthcare Executives, and past AHA RPB member, along with many local clubs and organizations. A Mainer born and raised in the Katahdin Region, Marie is deeply committed to rural healthcare. When not at work or volunteering, she enjoys spending time with her husband Dave and their two golden retrievers.
Rahul Vanjani
Founder and CEO, Docs for Health
Rahul Vanjani brings experience in healthcare strategy, operations, and leadership.
He has been involved in initiatives that bridge care delivery, innovation, and health systems improvement.
His background spans clinical, academic, and business environments, positioning him at the intersection of health and technology.
Michael Balsam
Chief Product Officer, Cecelia Health
Kathy Simmonds
Clinical Professor, School of Nursing within the Bouvé College of Health Sciences at the Roux Institute
Candace Nagaraja
Managing Director & Partner, LEK Consulting
Candace is a Managing Director in L.E.K.’s Healthcare practice, based in Atlanta, and serves as the U.S. Women’s Health Lead. She advises clients across medical devices, provider services, and consumer health, developing commercialization and go-to-market strategies, as well as supporting private equity and corporate diligence. With deep expertise in women’s health, she has led initiatives in diagnostics, MedTech, and maternal care, and partnered with nonprofits to expand access globally. Beyond women’s health, she advises on orthopedics, urology, and regenerative medicine, and leads data-driven strategy projects. Candace holds an MBA and an A.B. in Economics from the University of Chicago.
November 13, 9:45 AM–10:00 AM
HealthTech Hustle: Revenue Models That Work
Innovative health solutions don’t sell themselves, especially in today’s evolving and complex reimbursement environment. Whether you’re approaching hospital systems, adapting to changes in Medicare Advantage, or exploring direct-to-consumer models, your revenue strategy needs to reflect current market realities. This session explores how companies are navigating payment dynamics, what’s working in real-world scenarios, and how to align offerings with what payers, providers, and patients are actually willing to support. You’ll gain practical insights into the current dynamics and the strategies driving sustainable growth.
John Konsin
Principal Founder & CEO, Prapela, Inc.
For 45 years, John Konsin has focused solely on the challenges and rewards of commercializing Medical Technology innovations to improve human health. His latest endeavor is the Prapela SVS hospital bassinet pad, which restores healthy rhythmic breathing and heart rate in newborns. The device was granted FDA De Novo authorization on April 4, 2025, establishing a new category of medical devices: vibrational therapeutic pads for infants. Previously, five of the Top 25 Global Medical Device companies trusted John in leadership and executive roles. He led or assisted in generating over $5.4 billion in revenue and launched over 100 products. His experience includes work in Medical Devices, Diagnostics, Imaging, DME, Biologics, Wearables, and Genetics. He has worked closely with neonatologists, orthopedic surgeons, cardiologists, and physicians specializing in pain management. As a 2X CEO, his experience includes general management, marketing, sales, finance, HR, operations, R&D/product development, clinical research, quality, and regulatory affairs.
Tim McCarthy
VP, U.S. Operations, Theranica
Tim McCarthy leads U.S. operations at Theranica, a digital therapeutics company pioneering non-invasive migraine treatments.
He brings deep expertise in medical device commercialization and strategic market growth.
Owen McCarthy
Co-Founder & President, MedRhythms
Owen McCarthy is Co-Founder and President of MedRhythms, a digital therapeutics company harnessing the power of music and neuroscience to improve walking and mobility for people with neurological injuries and diseases.
Troy Trejo
Vice President of Strategy, MaineHealth
Troy Trejo drives healthcare innovation at MaineHealth, focusing on new models of care delivery and technology adoption to improve patient outcomes across the region.
Rodney Erb
Vice President, Clinical Data Integration & Analytics, The Audit Group (TAG)
Rodney Erb serves as Vice President of Clinical Data Integration & Analytics at The Audit Group (TAG), where he leads the development of advanced data platforms that unify supply chain, finance, and clinical teams across major health systems. With more than 30 years in healthcare, Rodney bridges clinical expertise and operational strategy to drive measurable savings and compliance through TAG’s suite of solution. His work focuses on leveraging analytics, automation, and strategic negotiation to improve hospital performance and transparency.
Kim Lynch
CEO, Metis Health Technologies
Kim Lynch is CEO and Founder of Metis Health Technologies. With over 20 years of experience in health tech, Kim has a proven track record of driving audacious leaps in data and technology to improve patient care, empower clinicians, and achieve the Triple now Quintuple Aim in healthcare transformation. Prior to founding Metis, Kim was part of the founding executive team at Aledade, where she played a pivotal role in building the company to a $3.1B valuation. She wakes up every day eager to put points on the board towards a more just healthcare system.
November 13, 10:45 AM–11:30 AM
Hospital at Home: Changes in Chronic & Long-Term Care
The next frontier of chronic care is happening at home. Advances in technology are enabling treatments once reserved for hospital settings to move into the living room. From mobile imaging units and home infusion therapies to remote patient monitoring, telehealth, and AI-enabled diagnostics, care is becoming more decentralized and accessible. Hospital-grade interventions are being reimagined through portable devices, while pharmacies and home health providers are evolving to support this shift. This session will explore the expanding ecosystem of hospital-at-home care, the technologies making it possible, and the challenges and opportunities of delivering high-acuity care where people live.
Todd Haedrich
Moderator
CEO, LIO
Todd Haedrich is the CEO of Lio Health, a global leader in contactless patient monitoring and digital rounding for the behavioral health industry. LIO helps to improve safety, reduce risk, while eliminating regulatory and administrative burdens. Before Oxehealth, Todd Haedrich was the CEO of Optimize Health, a leader in the Remote Patient Monitoring industry. Under Todd’s leadership, Optimize Health tripled revenue, made the Inc. 5000 list, and raised multiple rounds of capital. Todd has spent over two decades leading healthcare technology businesses. He spearheaded the commercial technology transformation of Covetrus, a global animal health technology, distribution, and services company. Before Covetrus, Todd was at athenahealth, where he held leadership roles in sales, customer success, and operations. Prior to diving into healthcare, Todd co-founded and exited several B2B software companies and was an investor at BancBoston Ventures. Before starting his career, Todd received a Computer Science B.A. from Bowdoin College.
Alex Arevalos, PhD
CEO, UBiosis
Alex Arevalos is a co-founder at UBiosis, an AI-driven platform focused on improving chronic GI condition follow-up through chatbot technology.
His work integrates artificial intelligence with clinical care pathways to enhance patient engagement and long-term outcomes.
Anders Sideris, MD, MS, MSE
CEO, Somnair
Dr. Anders Sideris is a medical doctor, inventor, biomedical innovator and physician-entrepreneur working at the intersection of medicine, surgery and engineering with a goal to create a world without ineffective, invasive and uncomfortable treatments for obstructive sleep apnoea, a disease affecting 1 billion people worldwide.
Dr. Sideris is currently a faculty member, innovation fellow and entrepreneur-in-residence at the Johns Hopkins Center for Bioengineering Innovation and Design where he leads and mentors teams to innovate and translate novel biomedical solutions for significant and unmet medical needs globally.
Pursuing his passion for biodesign and medical device innovation he moved to the United States to pursue a Masters of Biomedical Engineering, Innovation and Design at Johns Hopkins University which he completed in 2024. He serves as Co-Founder and Chief Executive Officer of Somnair, a pre-clinical medical device company developing non-invasive neurostimulation technology for the treatment of obstructive sleep apnea.
Previously, Dr. Sideris worked in Otolaryngology-Head and Neck Surgery departments as a medical officer and research fellow in large academic hospitals in Australia. In these roles he led multidisciplinary teams in adult and paediatric Otolaryngology-Head and Neck Surgery. His clinical and translational research focused on head and neck cancer, obstructive sleep apnoea and drug delivery technology for diseases of the head, neck and upper aerodigestive tract.
During his surgical training he co-founded Release Therapeutics, a pre-clinical stage biotechnology start-up created to commercialise polymeric drug-delivery combination-device technology developed during his Masters of Science (Research) at University of New South Wales, which he completed in 2021.
Dr Sideris was an Associate Lecturer and Researcher in the University of New South Wales Prince of Wales Clinical School and Surgical and Orthopaedic Research Laboraties from 2016 – 2021 where he taught medical students, junior doctors and led clincial and translational research projects in multiple surgical disciplines.
Dr. Sideris earned his Medical Degree at the University of Newcastle in 2015. He holds a Bachelor of Medical Sciences (Honours) from the University of Newcastle.
Dr. Sideris is a proud Aussie and avid surfer 🦘🇦🇺
Loredana Jinga
Sr. Director, Emerging Technologies, Danaher
Loredana Jinga is Vice President & Managing Partner at Optimal Strategix Group, helping clients unlock the “why” behind customer choices to accelerate growth and amplify value.
Loredana Jinga integrates scientific expertise, clinical experience, and strategic insight to drive innovation and deliver meaningful healthcare solutions from research to bedside. With a foundation in molecular biology, public health, clinical practice, and healthcare strategy, she translates complex data and real-world evidence into actionable, scalable approaches across diagnostics, biotech, and healthcare delivery. Her career spans clinical care and research at Massachusetts General Hospital/Harvard Medical School, strategic industry roles with Covidien, Medtronic, BD, and Danaher (Flow Cytometry – Chemistry – Oncology – Molecular Dx – + ), and public health leadership at U.S. Pharmacopeia. She has led global initiatives in translational research, commercialization, policy, and enterprise innovation—shaping markets and accelerating high-impact solutions. Known for her systems thinking and results-driven approach, Loredana advances patient-centered, data-powered
models that improve outcomes and reimagine the future of care.
Loredana Jinga’s academic foundation spans nursing, molecular and cell biology, epidemiology, health law and healthcare data analytics, with advanced training from institutions including Boston University, Harvard, and UCONN. She has authored peer-reviewed publications across phases I–IV clinical research and holds multiple patents, including innovations in anesthetic delivery and micro-pump wound care systems. A multi-award-winning innovator, she consistently pioneers solutions that challenge conventions, accelerate
growth, and deliver measurable value across healthcare and life sciences.
Steve Emrick
Senior Vice President, Clinical Informatics Solutions, PurpleLab
Steven Emrick is an informatics executive and digital business strategist who integrates real-world data, interoperability standards, and IoT to shape strategy and deliver scalable digital solutions. He leads product vision, roadmap, and commercialization for a clinical data platform, uniting clinical, regulatory, and standards teams to turn data into market-ready products.
Steven’s career spans senior roles across health data and standards: SVP at PurpleLab leading the HealthNexus™ platform; VP at Clinical Architecture driving strategic client growth and federal priorities; VP of Data Strategy & Enablement at Cepheid (Danaher) aligning >$100M connectivity/data opportunities; Senior Director at IMO building next-gen clinical content platforms; Director at U.S. Pharmacopeia creating standards-based digital products (e.g., USP Drug Classification, HazRx®); and a decade at the U.S. National Library of Medicine advancing national terminology standards (RxNorm, SNOMED CT, LOINC) and launching UMLS web services.
November 13, 11:30 AM–12:00 PM
State of the MedTech Industry: Bank of America Financing Update
Hear directly from Bruno Stembaum, Managing Director of Medical Technology Investment Banking at Bank of America, as he shares his perspective on the current and future state of medtech financing. With more than 15 years of experience advising both public and private companies, Bruno has led billions of dollars in M&A, equity, and debt transactions across the medical device and healthcare technology sectors.
This session will cover: Key trends shaping M&A activity, IPOs, and equity markets in medtech; the evolving role of private vs. public capital for early- and growth-stage companies; insights from landmark deals with leading strategics and investors; and what founders, executives, and investors should anticipate in the financing landscape for 2026 and beyond.
Whether you’re an entrepreneur preparing to raise capital, a strategic partner seeking to understand exit pathways, or an investor following the pulse of the market, this discussion will provide actionable intelligence from someone at the forefront of medtech dealmaking.
Bruno Stembaum
Managing Director
Medical Technology Investment Banking
Bank of America
Bruno Stembaum is the Managing Director of Medical Technology Investment Banking at Bank of America. With more than 15 years of experience advising both public and private companies, he has led billions of dollars in M&A, equity, and debt transactions across the medical device and healthcare technology sectors. Bruno brings expertise in guiding entrepreneurs, executives, and investors through the complexities of capital raising, IPOs, and strategic partnerships in the medtech industry.
November 13, 2:00 PM–2:30 PM
The AI Diagnosis Dilemma: Innovation Meets Skepticism
From reading scans to analyzing skin lesions, AI is rapidly emerging as a diagnostic tool, but can it be trusted? This session features a structured point-counterpoint discussion exploring the promise and pitfalls of AI in clinical decision-making. We’ll examine current use cases across specialties like radiology, oncology, and dermatology, while unpacking the regulatory, ethical, and cultural challenges that come with algorithm-driven diagnostics. As AI moves deeper into care delivery, the debate continues: How much trust is too much, and who gets to decide?
Ilsa Webeck
Moderator
VP, Commercialization Services & Marketing, Simbex
Ilsa Webeck is an experienced leader in the MedTech sector, guiding organizations through product development, market strategy, and innovation.
She is a frequent moderator and advisor, facilitating conversations that connect startups, clinicians, and investors.
Cheryl Ball
Senior Vice President – Strategy, Corporate Development, Lantheus
Cheryl Ball brings leadership experience from Lantheus, where she contributes to advancing diagnostics and therapeutics.
Her background includes driving organizational strategy, operational excellence, and collaboration within the life sciences sector.
Sam Scarpino
Director of AI + Life Sciences, Institute for Experiential AI, Northeastern University
Samuel V. Scarpino, PhD, is the Director of AI + Life Sciences in the Institute for Experiential AI and a Professor of Health Sciences at Northeastern University. He also holds faculty appointments in the Khoury College of Computer Sciences and the Network Science Institute. Prior to joining Northeastern, Scarpino was a Vice President at The Rockefeller Foundation, Chief Strategy Officer at Dharma Platform, and co-founded a data science initiative called Global.health, which has been supported by Google.org, The Rockefeller Foundation, and the Wellcome Trust. Outside of these roles, he has over 15 years of experience translating research into decision support and AI tools across diverse sectors from public health and clinical medicine to real estate and energy. In recognition for his contributions to complex systems science, he was named a fellow of the ISI Foundation in 2017 and an external Professor at the Santa Fe Institute in 2020.
Jennifer Monti, PhD
Health, Meta
Dr. Jennifer Monti is a cardiologist and critical care physician with broad experience driving innovation at the intersection of medicine, public health, and entrepreneurship.
She currently serves on the Health Tech team at Meta and as an Entrepreneur in Residence at the Roux Institute at Northeastern University, while also attending on the general cardiology service at Maine Medical Center and SSM Health. Board-certified in internal medicine, cardiology, and echocardiography, Dr. Monti has subspecialty expertise in cardiogenetic conditions affecting young people.
November 13, 3:15 PM–4:00 PM
Data-Driven Care: Playing to Win with Healthcare Analytics
Data is only powerful if it’s put to work, and across the country, healthcare innovators are proving what’s possible. This session explores real-world examples of how longitudinal patient data, advanced analytics, and modern platforms are transforming care delivery. From improving individual outcomes to enabling more personalized, proactive models of care, we’ll look at how data is being used to drive smarter decisions and more efficient systems. Whether you’re navigating massive datasets or rethinking patient engagement strategies, this session offers actionable insights into what data-driven care looks like in practice
Ken Shapiro
Co-Founder, Apricot
Ken Shapiro represents Apricot, bringing experience in health technology and commercialization.
His work spans strategy, innovation, and partnerships to advance healthcare solutions.
Prashant Mittal
Director of Professional Programs, Professor, The Roux Institute
Prashant Mittal is Director of professional programs and professor of AI and Analytics at the Roux Institute of Northeastern University. He formerly led data science teams at Lincoln Financial Group and directed the Analytics and Data Science program at the University of New Hampshire. He has over two decades of teaching experience and a strong research background in healthcare, having collaborated with major hospital systems and contributed to public health and education through his writing and research. His work spans across various sectors, integrating expertise in AI, biostatistics, data science and analytics.
Kate Ahrens
Principal Health Data Analyst, OnPoint Health Data
Kate is a Principal Health Data Analyst at Onpoint Health Data. She was previously an associate research professor in the Public Health Program at the University of Southern Maine, Muskie School of Public Service. Kate holds a bachelor’s degree from Harvard (Biology), an MPH from the University of Michigan (Epidemiology), and a PhD from Boston University (Epidemiology). She completed a post-doctoral fellowship at the Eunice Kennedy Shriver National Institute of Child Health and Human Development and was then a senior service fellow at the Office of Analysis and Epidemiology, National Center for Health Statistics, CDC, where she conducted research using data from national surveys and vital records. She was also a health scientist at the Office of Population Affairs, Office of the Assistant Secretary of Health. There she conducted analyses and provided program guidance related to family planning and reproductive health services in the US.
Richard Greenwald, PhD
Founder & Advisor, Simbex
Richard (Rick) Greenwald is an entrepreneur and biomedical engineer with more than 25 years of experience building companies,
developing novel technologies, and advancing medical device commercialization. He has led efforts in technology development,
intellectual property strategy, evaluation and licensing, strategic financing, and business growth.
As founder of Simbex, Rick grew the company into a recognized leader in biofeedback and data acquisition solutions for the medical and rehabilitation industries.
He is a Fellow of the National Academy of Inventors (NAI) and the American Institute of Medical and Biological Engineering (AIMBE), and holds 20 U.S. patents with five pending.
Rick also serves on the Boards of Trustees for the Visiting Nurse and Hospice for Vermont and New Hampshire and the New Hampshire Academy of Science.
He earned his PhD in Biomedical Engineering from Duke University, a Master of Science in Engineering from Dartmouth’s Thayer School of Engineering, and previously studied at the University of Utah.
David Wennberg
Strategic Advisor, Blue Health Intelligence
November 13, 4:00 PM–4:45 PM
Future-Proof: How Technology Will Enable Resilience in Healthcare
From pandemics to workforce strain, tomorrow’s challenges will test healthcare systems in ways we can’t fully predict. This forward-looking session explores what it takes to build true resilience in healthcare: from identifying emerging risks to designing systems that can adapt and endure. We’ll examine the signals worth watching, the structural shifts already underway, and the human-centered strategies that can help organizations prepare for uncertainty, respond to disruption, and lead through change.
Sue Mooney
President and CEO, Alice Peck Day Memorial Hospital
Sue Mooney is a confirmed speaker with deep experience in healthcare leadership and clinical transformation.
Her background includes guiding health systems through innovation, improving patient outcomes, and advancing organizational strategy.
She brings a strong track record of leading collaborative efforts across providers, patients, and communities.
Paul Bolin
Chief People & Administrative officer, Northern Light Health
Paul Bolin has dedicated his career to making Maine a great place to work and receive care. Following 14 years in the retail and manufacturing sectors, Paul joined Northern Light Health in 2005 and has been honored to serve in positions of increasing responsibility until his most recent promotion to the position of Executive Vice President, Chief People & Administrative Officer, serving over 11,000 employees in Maine. During his career, Paul has given back to Maine communities through many volunteer roles, some recent examples of which include the Maine State Chamber of Commerce Board, the Maine Bar Association’s Fee Arbitration Commission, Eastern Maine Community College’s Early Education Advisory Board, The University of Maine’s Maine Business School Advisory Board, the City of Bangor Planning Board, Educate Maine Board, and many others. Paul has also served in adjunct faculty roles and has presented on topics in both state and national conferences.
Andrew Jay
General Partner, Borna Health Fund
Dr. Jay has extensive experience in healthcare and investment management. In his previous role he ran Siemens Venture Capital’s Healthcare Fund and US. Operations. Prior to that, Dr. Jay served as a research analyst for nine years at Alex Brown, Deutsche Banc and Wachovia Securities, where he published extensive research on the medical device industry. Dr. Jay has participated in more than 30 equity transactions; raising over $2 billion in equity capital. Earlier, he was a consultant with Arthur D. Little, where he led projects across the healthcare universe with hospitals, payers, pharmaceutical companies and device manufacturers; helping them address various strategic and operational issues. Dr. Jay has held numerous board positions in both private and public companies.
Jenny Hoffmann
Executive Director, New England Medical Innovation Center (NEMIC)
Dr. Jenny Hoffmann is Executive Director of the New England Medical Innovation Center (NEMIC), where she leads efforts to accelerate medtech and healthtech innovation across the region. A bioengineer by training and entrepreneur by experience, she has held leadership roles spanning startups and industry, including CEO of a maternal-fetal monitoring company and leading medical device businesses at WL Gore & Associates. She is also co-founder of HA Biosciences and a fractional executive supporting early-stage ventures. Dr. Hoffmann earned her PhD in Bioengineering from Rice University and BS from the University of Virginia.